In recent years, the field of cancer care has made remarkable strides, offering new hope for patients battling these devastating diseases. One of the most exciting developments is the emergence of personalized cancer vaccines, which harness the power of the body's own immune system to fight cancer.
This innovative approach combines cutting-edge technologies such as artificial intelligence (AI) and our growing understanding of cancer biology to create...
MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.
In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.
Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.
